RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma
- DOI
- 10.3389/fimmu.2023.1286700
- Published
- 2023-11-15
- Container
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2023.1286700,
title = {RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma},
author = {Martina Emde-Rajaratnam and Susanne Beck and Vladimir Benes and Hans Salwender and Uta Bertsch and Christoph Scheid and Mathias Hänel and Katja Weisel and Thomas Hielscher and Marc S. Raab and Hartmut Goldschmidt and Anna Jauch and Ken Maes and Elke De Bruyne and Eline Menu and Kim De Veirman and Jérôme Moreaux and Karin Vanderkerken and Anja Seckinger and Dirk Hose},
year = {2023},
journal = {Frontiers in Immunology},
doi = {10.3389/fimmu.2023.1286700},
url = {https://doi.org/10.3389/fimmu.2023.1286700}
}RIS
TY - JOUR TI - RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma AU - Martina Emde-Rajaratnam AU - Susanne Beck AU - Vladimir Benes AU - Hans Salwender AU - Uta Bertsch AU - Christoph Scheid AU - Mathias Hänel AU - Katja Weisel AU - Thomas Hielscher AU - Marc S. Raab AU - Hartmut Goldschmidt AU - Anna Jauch AU - Ken Maes AU - Elke De Bruyne AU - Eline Menu AU - Kim De Veirman AU - Jérôme Moreaux AU - Karin Vanderkerken AU - Anja Seckinger AU - Dirk Hose PY - 2023 JO - Frontiers in Immunology DO - 10.3389/fimmu.2023.1286700 UR - https://doi.org/10.3389/fimmu.2023.1286700 ER -
APA
Emde-Rajaratnam, M., Beck, S., Benes, V., Salwender, H., Bertsch, U., Scheid, C., Hänel, M., Weisel, K., Hielscher, T., Raab, M. S., Goldschmidt, H., Jauch, A., Maes, K., Bruyne, E. D., Menu, E., Veirman, K. D., Moreaux, J., Vanderkerken, K., Seckinger, A., & Hose, D. (2023). RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1286700
Source records
- crossref · retrieved 2026-09-25T13:46:53.380Z